National Health Investors, Inc. (NYSE:NHI) Director Robert G. Adams purchased 2,000 shares of the company’s stock in a transaction dated Monday, December 14th. The shares were purchased at an average cost of $67.75 per share, for a total transaction of $135,500.00. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link.
Shares of NYSE:NHI traded down $0.25 during trading on Monday, hitting $66.78. The stock had a trading volume of 236,126 shares, compared to its average volume of 343,105. National Health Investors, Inc. has a 12-month low of $31.37 and a 12-month high of $91.12. The stock has a market capitalization of $2.99 billion, a price-to-earnings ratio of 15.73 and a beta of 0.79. The company has a quick ratio of 13.13, a current ratio of 13.13 and a debt-to-equity ratio of 1.02. The stock has a 50-day simple moving average of $62.47 and a two-hundred day simple moving average of $61.52.
National Health Investors (NYSE:NHI) last announced its quarterly earnings data on Monday, November 9th. The real estate investment trust reported $0.95 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.43 by ($0.48). National Health Investors had a return on equity of 12.64% and a net margin of 56.94%. The firm had revenue of $84.30 million during the quarter, compared to analysts’ expectations of $82.87 million. During the same quarter in the previous year, the business earned $1.42 earnings per share. The company’s revenue for the quarter was up 3.2% compared to the same quarter last year. As a group, sell-side analysts forecast that National Health Investors, Inc. will post 5.63 earnings per share for the current year.
Andrew Keene was “down and out”… until he found an obscure 18-digit “code” that let him see when hedge funds were making incredibly lucrative trades. He realized he could follow along – and take a slice of the profit. He’s now a multi-millionaire.
A number of research firms have recently issued reports on NHI. Berenberg Bank downgraded National Health Investors from a “buy” rating to a “hold” rating in a research report on Wednesday, December 2nd. Zacks Investment Research raised National Health Investors from a “sell” rating to a “hold” rating in a research report on Thursday, November 19th. ValuEngine downgraded National Health Investors from a “hold” rating to a “sell” rating in a research report on Thursday, October 1st. Stifel Nicolaus reaffirmed a “hold” rating and set a $63.00 price objective on shares of National Health Investors in a research report on Tuesday, September 1st. Finally, KeyCorp raised National Health Investors from an “underweight” rating to a “sector weight” rating in a report on Monday. One research analyst has rated the stock with a sell rating and nine have issued a hold rating to the company’s stock. National Health Investors currently has a consensus rating of “Hold” and an average target price of $65.88.
Large investors have recently made changes to their positions in the company. Marshall Wace North America L.P. purchased a new position in shares of National Health Investors in the first quarter worth about $31,000. Private Advisor Group LLC purchased a new position in shares of National Health Investors in the second quarter worth about $31,000. Van ECK Associates Corp raised its stake in shares of National Health Investors by 23.5% in the third quarter. Van ECK Associates Corp now owns 1,298 shares of the real estate investment trust’s stock worth $78,000 after purchasing an additional 247 shares during the last quarter. Avantax Advisory Services Inc. purchased a new position in shares of National Health Investors in the third quarter worth about $202,000. Finally, Campbell & CO Investment Adviser LLC purchased a new position in National Health Investors during the third quarter valued at approximately $209,000. Hedge funds and other institutional investors own 62.41% of the company’s stock.
About National Health Investors
Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI’s portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.
Recommended Story: Blockchain
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to [email protected]
When a single Wall Street analyst downgrades one of your stocks, you might think they are just having a bad day or have an incorrect investment thesis. One downgrade typically won’t have a significant impact on the price of one of your stocks, but what if analysts repeatedly downgraded a company over the last 30, 60, or 90 days? You would know something is seriously wrong.
Today, we invite you to take a free exclusive look at our up-to-the-minute list of 12 “Most Downgraded” stocks. These are true strong sell stocks. Analysts are abandoning them in droves and issuing rare downgrades and sell ratings. If any of these stocks are lurking around in your portfolio, seriously consider whether or not they still belong in your portfolio.